Ledger.Open graph →
SEC Form D · filed May 27, 2021

Interius BioTherapeutics, Inc

Offering
$76.3M
Sold
$43.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Benjamin R. Lund · Philadelphia, PADirectorLeon R. Moulder, Jr · Miromar Lakes, FLDirectorDora R. Mitchell · Philadelphia, PAExecTomas R. Kiselak · Philadelphia, PADirectorPhilip R. Johnson, M.D · Philadelphia, PAExec · DirectorPeter A. Sherlock · Westport, CTDirectorVenkat Subramanian · SEATTLE, WAExec · DirectorCourtney A. Oliver · Westport, CTDirectorMichael Dale · West Newton, MAExecDavid Cotter · Tacoma, WADirectorLori R. Forrest · Philadelphia, PAExecBrandon E. Fitch · New York, NYExecPatrick C. Condo · Vienna, VADirectorCraig B. Prenter · Burnaby, British Columbia, CanadaDirectorAndy Wang · San Francisco, CADirectorSharyn A. Alexander · Duncan, British Columbia, CanadaExec · DirectorLori R. Forrest · Philadelphia, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗